Recently, the US Food and Drug Administration (FDA) issued regulations requiring drug manufacturers to more clearly explain the risks and side effects of prescription drugs.

The regulations will take effect from November 20.

The FDA has spent more than 15 years developing new guidelines to eliminate practices that distract consumers from drug risk information, such as using medical jargon or eye-catching images.

Specifically, these regulations require drug manufacturers to use simpler language, avoid distractions, and ensure that information about drug risks and side effects is presented in a clear and concise manner. compact.

According to ispot.tv, television drug advertising remains the pharmaceutical industry’s main form of advertising, with more than $4 billion spent last year.

These ads often use music, sounds, upbeat images, or the reputation of social media influencers to distract from warnings about side effects or to fake the message.

While the new FDA regulations are considered an improvement, experts warn that certain requirements, such as displaying side effects on the screen when playing audio notifications, may still leading to information overload, which is counterproductive and makes it harder for viewers to take risks.

In addition, experts also assess that the new regulations will have little impact on the overall tone and appearance of advertising.

A new challenge has emerged as more and more social media influencers promote pharmaceutical products.

As a result, the FDA regulation unintentionally created a “loophole” for both influencers and healthcare companies that do not have a direct financial connection to the manufacturers of the drugs they sell.

In response, the US government is considering a bill that would expand the FDA’s authority to regulate influencer advertising programs, requiring full disclosure of risks and compensation, if any.